Letter in response to: circulating von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality.

Bhogal, P; Paul, G; Collins, G; Jaffer, O

Bhogal, P; Paul, G; Collins, G; Jaffer, O.

Bhogal P; Department of Interventional Neuroradiology, The Royal London Hospital, Barts NHS Trust, Whitechapel Road, London, E1 1BB, UK. Paul.bhogal@nhs.net.
Paul G; Department, of Gastroenterology, Hepatology, Pneumology and Infectious Diseases, Katharinenhospital, Klinikum Stuttgart, Krigesbergstraße 60, 70174, Stuttgart, Germany.
Collins G; Department of Cardiology, St. Bartholomew's Hospital, Barts NHS Trust, London, UK.
Jaffer O; Department of Interventional Radiology, The Royal London Hospital, Barts NHS Trust, London, UK.

Angiogenesis ; 24(3): 413-415, 2021 08.

Article in English | MEDLINE | ID: covidwho-1260598

Subject(s)

COVID-19; von Willebrand Factor; Hospital Mortality; Humans; Molecular Weight; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Von Willebrand Factor / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Angiogenesis Journal subject: Hematology Year: 2021 Document Type: Article Affiliation country: S10456-021-09790-w

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google